13 oC 
Güneşli
Iceland’s Health Directorate has suspended Moderna’s coronavirus vaccine, citing concerns of increased risks of cardiac inflammation.
“The Epidemiologist has decided not to use the Moderna vaccine in Iceland while providing further information on the safety of the Moderna vaccine,” the directorate said.
So far, Iceland has fully vaccinated more than 88 percent (370,000 locals) of the eligible population, of ages 12 and above.
On Thursday, Sweden decided to suspend the use of Moderna's COVID-19 shots for those aged 30 and under, while Denmark did the same for those under 18 after the study had shown a potential increase in the risk of myocarditis and pericarditis among young people.
The Moderna COVID‑19 vaccine, codenamed mRNA-1273 and sold under the brand name Spikevax, is a COVID-19 vaccine developed by American company Moderna, the United States National Institute of Allergy and Infectious Diseases (NIAID), and the Biomedical Advanced Research and Development Authority (BARDA).
It is authorized for use in people aged twelve years and older in some jurisdictions and for people eighteen years and older in other jurisdictions to provide protection against COVID-19 which is caused by infection by the SARS-CoV-2 virus.
It is designed to be administered as two or three 0.5 mL doses given by intramuscular injection at an interval of at least 28 days apart.
On June 23, the US Centers for Disease Control and Prevention (CDC) confirmed that myocarditis or pericarditis occurs in about 13 of every 1 million young people, mostly male and over the age of 16, who received the Moderna or the Pfizer–BioNTech vaccine. (ILKHA)
LEGAL WARNING: All rights of the published news, photos and videos are reserved by İlke Haber Ajansı Basın Yayın San. Trade A.Ş. Under no circumstances can all or part of the news, photos and videos be used without a written contract or subscription.
İpek Baz, Chair of the Women’s Branch of the HÜDA PAR Diyarbakır Provincial Directorate, has drawn attention to a growing crisis in women’s healthcare access in Türkiye’s southeastern region.
In 2024, Türkiye recorded significant internal migration, with 2,682,673 people relocating across provinces, according to data released by the Turkish Statistical Institute (TurkStat) on Monday.
A child has died from measles at Alder Hey Children’s Hospital in Liverpool, marking the second child fatality from the virus in the UK this decade, health officials have confirmed.
As the world commemorates World Population Day, a United Nations initiative launched in 1989 to raise awareness about population and development challenges, the latest 2024 United Nations population estimates position Türkiye as a significant player in global demographics.
